IGFBP-3 Antibody (IGFBP3/3423) [DyLight 680]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-24250FR
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunohistochemistry-Paraffin
Label
DyLight 680 (Excitation = 692 nm, Emission = 712 nm)
Antibody Source
Monoclonal Mouse IgG2b Kappa Clone # IGFBP3/3423
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for IGFBP-3 Antibody (IGFBP3/3423) [DyLight 680]
Immunogen
Recombinant human full-length IGFBP-3 protein
Localization
Secreted. Localized to vesicles, cytosol and nucleoplasm.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2b Kappa
Applications for IGFBP-3 Antibody (IGFBP3/3423) [DyLight 680]
Application
Recommended Usage
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: IGFBP-3
Long Name
Insulin-like Growth Factor Binding Protein 3
Alternate Names
IGFBP3
Gene Symbol
IGFBP3
Additional IGFBP-3 Products
Product Documents for IGFBP-3 Antibody (IGFBP3/3423) [DyLight 680]
Product Specific Notices for IGFBP-3 Antibody (IGFBP3/3423) [DyLight 680]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...